MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
194.10%
Quick Ratio
179.07%
Cash Ratio
63.62%
Debt to Asset Ratio
18.36%
Unit: Thousand (K) dollars
Assets Breakdown
Deferred income tax asset
Cash and cash equivalents
Accounts receivable, net
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Loans payable, net, current
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
60,816
24,411
40,580
48,534
Short-term investments
34,513
122,273
114,375
88,609
Accounts receivable, net
56,041
49,945
51,763
45,925
Inventories
14,367
11,652
11,506
13,303
Prepaid and other current assets
19,792
25,746
21,942
18,556
Total current assets
185,529
234,027
240,166
214,927
Property and equipment, net
-
-
-
54
Intangible assets, net
93,878
24,160
24,748
25,336
Deferred income tax asset
238,068
243,279
245,852
-
Operating lease right-of-use assets
647
785
920
1,050
Other assets
2,944
2,357
1,908
1,167
Total assets
521,066
504,608
513,594
242,534
Accounts payable
4,011
4,486
7,191
3,846
Accrued compensation
8,611
6,009
11,914
10,065
Accrued research and development
6,932
5,742
5,524
4,816
Acquisition-related liabilities
218
5,000
5,000
5,000
Revenue reserves and refund liability
27,974
28,080
27,716
30,020
Loans payable, net, current
39,236
29,865
29,812
29,761
Other accrued liabilities
7,948
9,674
-
8,943
Deferred revenue
-
-
-
1,355
Other current liabilities
-
-
11,466
-
Lease liabilities, current
656
636
614
594
Total current liabilities
95,586
89,492
99,237
94,400
Acquisition-related liabilities
-
-
0
-
Lease liabilities, non-current
58
228
395
556
Loans payable, net, non-current
0
14,991
22,482
29,969
Other long-term liabilities
-
-
0
-
Total liabilities
95,644
104,711
122,114
124,925
Common stock
18
18
18
18
Additional paid-in capital
1,422,649
1,414,394
1,414,322
1,408,601
Accumulated other comprehensive (loss) income
-148
-128
181
96
Accumulated deficit
-997,097
-1,014,387
-1,023,041
-1,291,106
Total stockholders equity
425,422
399,897
391,480
117,609
Total liabilities and stockholders equity
521,066
504,608
513,594
242,534
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$60,816K
(13.87%↑ Y/Y)
Accounts receivable, net
$56,041K
(40.43%↑ Y/Y)
Short-term investments
$34,513K
(-37.22%↓ Y/Y)
Prepaid and other
current assets
$19,792K
(18.63%↑ Y/Y)
Inventories
$14,367K
(37.84%↑ Y/Y)
Deferred income tax asset
$238,068K
Total current assets
$185,529K
(5.78%↑ Y/Y)
Intangible assets, net
$93,878K
(262.13%↑ Y/Y)
Other assets
$2,944K
(-29.64%↓ Y/Y)
Operating lease
right-of-use assets
$647K
(-45.08%↓ Y/Y)
Total assets
$521,066K
(152.04%↑ Y/Y)
Total liabilities and
stockholders equity
$521,066K
(152.04%↑ Y/Y)
Total stockholders
equity
$425,422K
(419.23%↑ Y/Y)
Total liabilities
$95,644K
(-23.36%↓ Y/Y)
Accumulated deficit
-$997,097K
(24.41%↑ Y/Y)
Accumulated other
comprehensive (loss) income
-$148K
(-2566.67%↓ Y/Y)
Additional paid-in capital
$1,422,649K
(1.55%↑ Y/Y)
Total current
liabilities
$95,586K
(10.33%↑ Y/Y)
Lease liabilities,
non-current
$58K
(-91.88%↓ Y/Y)
Common stock
$18K
(0.00%↑ Y/Y)
Loans payable, net,
current
$39,236K
(75.47%↑ Y/Y)
Revenue reserves and
refund liability
$27,974K
(-5.18%↓ Y/Y)
Accrued compensation
$8,611K
(9.04%↑ Y/Y)
Other accrued
liabilities
$7,948K
(-7.51%↓ Y/Y)
Accrued research and
development
$6,932K
(68.21%↑ Y/Y)
Accounts payable
$4,011K
(-44.98%↓ Y/Y)
Lease liabilities,
current
$656K
(26.89%↑ Y/Y)
Acquisition-related liabilities
$218K
(-95.64%↓ Y/Y)
Buy us a coffee
RIGEL PHARMACEUTICALS INC (RIGL)
RIGEL PHARMACEUTICALS INC (RIGL)